FDA needs industry support on nanotechnology (Nutraingredients.com)
10/9/2006 - A former FDA deputy commissioner for policy reiterated the need for industry to show its support for an increased budget for the federal agency, following a report last week denouncing its capacity to properly regulate nanotechnology products.

Generic Threat Puts Biologic Firms On The Defensive (Investor's Business Daily via Yahoo! News)
Technology marches on, but the law and regulations often don't keep up. That's been the case with biological drugs, which are made from proteins instead of chemicals.

Most pharma scrips move up in line with BSE Sensex (PharmaBiz)
The Bombay Sock Exchange Sensex of 30 leading companies touched to its all-time high level at 12,756 with strong support from foreign financial institutions and general investors.